Literature DB >> 31202869

Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis.

Alexander Egeberg1, Jacob P Thyssen2.   

Abstract

BACKGROUND: Factors that are associated with patient-reported importance of obtaining complete or almost complete clearance of psoriasis and atopic dermatitis (AD) are unknown.
OBJECTIVES: To investigate the importance of and factors associated with obtaining complete or almost complete clearance of psoriasis or AD.
METHODS: A cross-sectional study of 4016 and 3842 adults with psoriasis and AD.
RESULTS: Patients with AD reported significantly greater importance of almost complete or complete skin clearance compared with patients with psoriasis. For both patient groups, almost complete was more important that complete skin clearance. Increasing disease severity and itch and skin pain were significantly associated with perceived importance of skin clearance for patients with both diseases. AD and psoriasis located on the face or neck and psoriasis located on the palms, soles, or genitals were significantly associated with patient-perceived importance of almost complete skin clearance. Only 7% and 27% of patients with severe AD and psoriasis, respectively, were currently receiving a systemic therapy. LIMITATIONS: Specific reasons for infrequent use of systemic treatments was not examined.
CONCLUSION: Patients with psoriasis or AD expressed a strong request for almost complete or complete skin clearance. Patient education and effective therapies should be used to reduce disease severity.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Danish Skin Cohort; atopic dermatitis; epidemiology; psoriasis; treatment goals

Mesh:

Substances:

Year:  2019        PMID: 31202869     DOI: 10.1016/j.jaad.2019.06.018

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide Study.

Authors:  Nikolai Loft; Alexander Egeberg; Mads Kirchheiner Rasmussen; Lars Erik Bryld; Christoffer V Nissen; Tomas Norman Dam; Kawa Khaled Ajgeiy; Lars Iversen; Lone Skov
Journal:  Acta Derm Venereol       Date:  2021-01-04       Impact factor: 3.875

2.  Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series.

Authors:  L E M de Wijs; N T Nguyen; A C M Kunkeler; T Nijsten; J Damman; D J Hijnen
Journal:  Br J Dermatol       Date:  2019-12-22       Impact factor: 9.302

3.  Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study.

Authors:  Andrew Alexis; Marjolein de Bruin-Weller; Stephan Weidinger; Weily Soong; Sebastien Barbarot; Ileana Ionita; Fan Zhang; Hernan Valdez; Claire Clibborn; Natalie Yin
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-17

4.  Care pathways in atopic dermatitis: a retrospective population-based cohort study.

Authors:  L von Kobyletzki; N Ballardini; D Henrohn; M P Neary; G Ortsäter; K Geale; A Rieem Dun; I Lindberg; A De Geer; P Neregård; A Cha; J C Cappelleri; W Romero; J P Thyssen
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-05-18       Impact factor: 9.228

5.  High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents.

Authors:  S Ständer; N Bhatia; M J Gooderham; J I Silverberg; J P Thyssen; P Biswas; M DiBonaventura; W Romero; S A Farooqui
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-05-06       Impact factor: 9.228

6.  Is Clear Always Clear? Comparison of Psoriasis Area and Severity Index (PASI) and the Physician's Global Assessment (PGA) in Psoriasis Clearance.

Authors:  Albert G Wu; Jade Conway; Lauren Barazani; Bipasha Roy; Abigail Cline; Frederick Pereira
Journal:  Dermatol Ther (Heidelb)       Date:  2020-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.